Trademark: 78709157
Word
CELIVIV
Status
Dead
Status Code
606
Status Date
Monday, September 14, 2009
Serial Number
78709157
Mark Type
4000
Filing Date
Thursday, September 8, 2005
Published for Opposition
Tuesday, May 23, 2006
Abandoned Date
Monday, September 14, 2009

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines

Trademark Events
Sep 14, 2009
Abandonment Notice Mailed - No Use Statement Filed
Sep 14, 2009
Abandonment - No Use Statement Filed
Jul 6, 2009
Attorney Revoked And/Or Appointed
Jul 6, 2009
Teas Revoke/Appoint Attorney Received
Dec 18, 2008
Extension 5 Granted
Dec 18, 2008
Extension 5 Filed
Dec 18, 2008
Teas Extension Received
Dec 17, 2008
Attorney Revoked And/Or Appointed
Dec 17, 2008
Teas Revoke/Appoint Attorney Received
Jul 29, 2008
Extension 4 Granted
Jul 29, 2008
Extension 4 Filed
Jul 29, 2008
Teas Extension Received
Jan 14, 2008
Extension 3 Granted
Jan 14, 2008
Extension 3 Filed
Jan 14, 2008
Teas Extension Received
Jul 10, 2007
Extension 2 Granted
Jul 10, 2007
Extension 2 Filed
Jul 10, 2007
Teas Extension Received
Jan 15, 2007
Extension 1 Granted
Jan 15, 2007
Extension 1 Filed
Jan 15, 2007
Teas Extension Received
Aug 15, 2006
Noa Mailed - Sou Required From Applicant
Jun 5, 2006
Assigned To Examiner
May 23, 2006
Published For Opposition
May 3, 2006
Notice Of Publication
Apr 6, 2006
Law Office Publication Review Completed
Apr 3, 2006
Assigned To Lie
Mar 24, 2006
Approved For Pub - Principal Register
Mar 20, 2006
Assigned To Examiner
Sep 15, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24